Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine 2000 June;44(2) > The Quarterly Journal of Nuclear Medicine 2000 June;44(2):112-20

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


eTOC

 

  ECONOMICS OF NUCLEAR MEDICINE
Guest Editor: Gambhir S. S.


The Quarterly Journal of Nuclear Medicine 2000 June;44(2):112-20

language: English

The role of cost effectiveness analysis in health care evaluation

Atherly A., Culler S. D., Becker E. R.

From the Department of Health Policy and Management Rollins School of Public Health Emory University, Atlanta, GA, USA


FULL TEXT  REPRINTS


This ­paper pro­vides an over­view of the key ele­ments of ­cost effec­tive­ness anal­y­sis (CEA). CEA is a meth­od for eval­u­at­ing the rel­a­tive ­costs and ben­e­fits of treat­ments and pro­ce­dures. Typically, CEA com­pares a pro­posed inter­ven­tion ­with (at ­least) one alter­na­tive inter­ven­tion, yield­ing an incre­men­tal ­cost effec­tive­ness ­ratio. This ­ratio ­reflects ­both the lon­gev­ity and ­health stat­us of the dif­fer­ing inter­ven­tions and per­mits the research­er to ­more com­plete­ly com­pare and eval­u­ate the “pay­off” of the inter­ven­tions. This ­paper dis­cuss­es dif­fer­ent per­spec­tives CEA stud­ies ­might ­adopt, and ­reviews the ­major meth­ods for meas­ur­ing ­both out­comes and ­costs.

top of page